Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment


Episode Artwork
1.0x
0% played 00:00 00:00
Feb 05 2025 4 mins   13

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.